The European Commission (EC) has approved a Marketing Authorization (MA) for Lazcluze (lazertinib), in combination with ...
US healthcare giant Johnson & Johnson announced the US Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Spravato (esketamine) CIII nasal spray as the first ...
Staff and residents at Barchester’s Glenroyd care home in Blackpool were treated to a virtual tour of JandJ Alpacas, a family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback